Shares of Zur Rose Group AG (OTCMKTS:ZRSEF – Get Rating) have earned a consensus recommendation of “Hold” from the ten research firms that are presently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $72.40.
A number of research analysts have recently issued reports on ZRSEF shares. Jefferies Financial Group raised Zur Rose Group from a “hold” rating to a “buy” rating in a research note on Monday, February 6th. Citigroup raised Zur Rose Group from a “sell” rating to a “neutral” rating in a research note on Monday, February 6th. Finally, Deutsche Bank Aktiengesellschaft raised Zur Rose Group from a “sell” rating to a “hold” rating in a research note on Monday, February 6th.
Zur Rose Group Price Performance
Shares of OTCMKTS:ZRSEF opened at $53.37 on Tuesday. The business’s 50-day moving average is $37.59 and its 200-day moving average is $36.48. Zur Rose Group has a 1 year low of $23.64 and a 1 year high of $185.00.
Zur Rose Group Company Profile
Zur Rose Group AG engages in the operation of an e-commerce pharmacy and the wholesale of medical and pharmaceutical products. It operates through the following geograpical segments: Switzerland, Germany, and Europe. The company was founded by Walter Oberhänsli on April 6, 1993 and is headquartered in Frauenfeld, Switzerland.
- Get a free copy of the StockNews.com research report on Zur Rose Group (ZRSEF)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Zur Rose Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zur Rose Group and related companies with MarketBeat.com's FREE daily email newsletter.